You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PolyICLC

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +10 more
  • Atlanta, Georgia
  • +6 more
Mar 1, 2022

Prostate Cancer Trial in New York (Intratumoral (IT) Poly ICLC 0.5 mg, Intratumoral (IT) Poly ICLC 1.0 mg, Intramuscular (IM)

Completed
  • Prostate Cancer
  • Intratumoral (IT) Poly ICLC 0.5 mg
  • +3 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Sep 8, 2022

Melanoma, Metastatic Melanoma, Mucosal Melanoma Trial in Houston, Charlottesville (Peptide Vaccine (LPV7) + Tetanus peptide,

Unknown status
  • Melanoma
  • +2 more
  • Peptide Vaccine (LPV7) + Tetanus peptide
  • +3 more
  • Houston, Texas
  • +1 more
Nov 15, 2020

Primary Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Philadelphia (OC-L, Montanide, poly-ICLC

Terminated
  • Primary Ovarian Cancer
  • +2 more
  • OC-L
  • +2 more
  • Philadelphia, Pennsylvania
    Ovarian Cancer Research Center
Apr 23, 2020

Glioma, Malignant, Antigen-specific Vaccines, Individualized Treatment Trial in Shanghai (NeoPep Vaccine1 plus Poly-ICLC, NeoPep

Recruiting
  • Glioma, Malignant
  • +2 more
  • NeoPep Vaccine1 plus Poly-ICLC
  • NeoPep Vaccine2 plus Poly-ICLC
  • Shanghai, Shanghai, China
    Shanghai 10th People's Hospital
Oct 7, 2022

Allergic Rhinitis, Asthma, Latent Tuberculosis Trial in Paddington (Poly ICLC, Poly I:C, R848)

Completed
Has Results
  • Allergic Rhinitis
  • +2 more
  • Poly ICLC
  • +5 more
  • Paddington, London, United Kingdom
    Imperial Clinical Respiratory Research Unit (ICRRU), St Mary's H
Nov 3, 2021

Breast Cancer Trial in Charlottesville (poly-ICLC, 9 Peptides from Her-2/neu, CEA, & CTA, Peptide-tet)

Terminated
  • Breast Cancer
  • poly-ICLC
  • +2 more
  • Charlottesville, Virginia
    University of Virginia Health System
May 7, 2020

Melanoma, Head Neck Cancer, Sarcoma Trial in United States (Hiltonol)

Completed
  • Melanoma
  • +3 more
  • Hiltonol
  • Chevy Chase, Maryland
  • +4 more
Dec 15, 2020

Acute Myeloid Leukemia, Alkylating Agent-Related Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Buffalo

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jan 16, 2020

Glioblastoma Trial in Worldwide (APVAC1 vaccine plus Poly-ICLC and GM-CSF, APVAC2 vaccine plus Poly-ICLC and GM-CSF)

Completed
  • Glioblastoma
  • APVAC1 vaccine plus Poly-ICLC and GM-CSF
  • APVAC2 vaccine plus Poly-ICLC and GM-CSF
  • Copenhagen, Denmark
  • +5 more
Aug 6, 2018

Melanoma Trial in Charlottesville (pBCAR3-phosphopeptide, pIRS2-phosphopeptide, 2-MpP (pBCAR3-phosphopeptide +

Completed
  • Melanoma
  • pBCAR3-phosphopeptide
  • +2 more
  • Charlottesville, Virginia
    University of Virginia
Aug 11, 2016

Melanoma Trial in Charlottesville (MELITAC 12.1 + Montanide ISA-51 + lipopolysaccharide (LPS), MELITAC 12.1 + Montanide ISA-51 +

Completed
  • Melanoma
  • MELITAC 12.1 + Montanide ISA-51 + lipopolysaccharide (LPS)
  • MELITAC 12.1 + Montanide ISA-51 + polyICLC
  • Charlottesville, Virginia
    University of Virginia
Aug 11, 2016

HIV-1 Infected Adults With Chronic HIV-1 Infection Trial in New York (Arm A: Poly-ICLC, Arm B: Normal Saline)

Completed
Has Results
  • HIV-1 Infected Adults With Chronic HIV-1 Infection
  • Arm A: Poly-ICLC
  • Arm B: Normal Saline
  • New York, New York
    The Rockefeller University Hospital
Feb 13, 2018